Debevoise & Plimpton LLP offers clients ‘significant experience in the full range of PE transactions’, including domestic and cross-border leveraged buyouts as well as PIPE deals, continuation fund transactions, and take-private acquisitions. Integrated cross-practice expertise in antitrust, tax, finance, and IP matters furthermore enables the team to guide clients through all stages of complexly structured acquisition, including joint governance matters as well as antitrust reviews. The New York-based team, which is particularly active across transactions in the healthcare and industrials sectors, is led by Kevin Schmidt, who stands out for his advice on cross-border acquisitions, joint ventures, and strategic investments. Experienced partner Paul Bird is noted for his M&A experience as well as his ability to handle spin-offs and takeover defense matters, and Kevin Rinker is a key contact for private equity deals in the healthcare and life sciences space. Further key contacts include Uri Herzberg and Jennifer Chu, who are sought out by leading funds such as Clayton, Dubilier & Rice in connection with high-value acquisitions, as well as Christopher Anthony, who handles a wide range of public and private M&A.